Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-20

Clinical Trial Update: Clinical Trial of Topical ABL01 Treatment of Onychomycosis [NA]

View source ↗

Summary

This document notes the completion of a clinical trial evaluating topical ABL01 for toenail onychomycosis. The sponsor listed is Abbell AB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABL01

Snippet

Sponsor: Abbell AB | Conditions: Onychomycosis of Toenail | NA | Status: COMPLETED